AMAG PHARMACEUTICALS, INC. — key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2019)

$326.5M

Net Income/Loss (FY2019)

-$467.7M

Total Assets (FY2019)

$791.2M

Total Equity (FY2019)

$279.8M

Cash Flows from Operating Activities (FY2019)

-$125.7M

Source: AMAG PHARMACEUTICALS, INC. 10-K/A filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.